Pictet Asset Management (UK)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Pictet Asset Management (UK)’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,000	Closed	-$187K	–	1836
2020 Q4	$187K	Hold	12,000	–	–	﹤0.01%	1629
2020 Q3	$113K	Buy	+12,000	New	+$130K	﹤0.01%	1490
2020 Q1	–	Sell	-1,350,377	Closed	-$11.3M	–	1162
2019 Q4	$11.3M	Buy	1,350,377 +715,436	+113%	+$6.58M	0.02%	553
2019 Q3	$5.75M	Hold	634,941	–	–	0.01%	676
2019 Q2	$6.84M	Buy	634,941 +200,000	+46%	+$2.13M	0.01%	616
2019 Q1	$4.15M	Buy	434,941 +3,947	+0.9%	+$40.3K	0.01%	742
2018 Q4	$4.95K	Buy	430,994 +80,486	+23%	+$1,000K	0.01%	672
2018 Q3	$5.94M	Buy	350,508 +50,903	+17%	+$774K	0.01%	687
2018 Q2	$4.25M	Buy	+299,605	New	+$4.98M	0.01%	697

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Pictet Asset Management (UK)'s SGMO Position: Q1 2021 in Review

Pictet Asset Management (UK) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2021, closing a stake of 12,000 shares — an estimated $187K sold.

Pictet Asset Management (UK) first reported a position in SGMO in Q2 2018 and held it in 9 quarters. The position peaked at $11.3M in Q4 2019. 203 funds tracked by Wall St. Rank hold SGMO as of Q1 2021.

Pictet Asset Management (UK) reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
Pictet Asset Management (UK) sold 12,000 SANGAMO THERAPEUTICS INC shares in Q1 2021, an estimated $187K.
Pictet Asset Management (UK) first reported a position in SANGAMO THERAPEUTICS INC in Q2 2018 and held it in 9 quarters.
Pictet Asset Management (UK)'s SANGAMO THERAPEUTICS INC position peaked at $11.3M in Q4 2019.
203 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2021, filed 17 May 2021.